Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xenon Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
XENE
Nasdaq
2834
https://www.xenon-pharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
- Apr 16th, 2024 12:30 pm
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Apr 10th, 2024 12:30 pm
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 4th, 2024 8:01 pm
Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans
- Mar 19th, 2024 10:16 am
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
- Mar 12th, 2024 8:01 pm
Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
- Mar 9th, 2024 4:55 am
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
- Mar 5th, 2024 9:01 pm
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
- Mar 2nd, 2024 1:37 pm
Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
- Mar 1st, 2024 1:35 pm
Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results
- Feb 29th, 2024 9:34 pm
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Feb 29th, 2024 9:01 pm
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
- Feb 22nd, 2024 9:01 pm
3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
- Feb 22nd, 2024 3:08 am
Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?
- Feb 7th, 2024 10:04 am
Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
- Jan 23rd, 2024 1:36 pm
Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a Bet
- Jan 19th, 2024 2:55 pm
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
- Jan 8th, 2024 1:00 pm
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 1:30 pm
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Dec 4th, 2023 9:16 pm
After losing 5.2% in the past year, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) institutional owners must be relieved by the recent gain
- Dec 4th, 2023 11:30 am
Scroll